Regeneron Pharmaceuticals Inc. (REGN) started off 2018 in the midst of a downtrend, which persisted until May 2018 when the stock started to stage some sort of a comeback. However, it has to be determined if this comeback can be termed a true trend reversal, or merely a retracement of the down…